Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
UBS
Baxter
Deloitte
Teva
Covington
Dow
QuintilesIMS
Mallinckrodt
Johnson and Johnson

Generated: February 23, 2018

DrugPatentWatch Database Preview

Actavis Labs Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS, and what generic and branded alternatives to ACTAVIS LABS drugs are available?

ACTAVIS LABS has one hundred and six approved drugs.

There are three tentative approvals on ACTAVIS LABS drugs.

Summary for Actavis Labs
US Patents:0
Tradenames:82
Ingredients:73
NDAs:106

Drugs and US Patents for Actavis Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062031-002 Oct 13, 1982 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Labs Ny Inc NICOTINE POLACRILEX nicotine polacrilex GUM, CHEWING;BUCCAL 076568-002 Jul 29, 2004 OTC No No ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc CIPROFLOXACIN EXTENDED RELEASE ciprofloxacin; ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 077809-001 Nov 30, 2010 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc FENTANYL-50 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076709-002 Aug 20, 2007 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076267-004 Feb 11, 2004 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Labs Fl GUAIFENESIN guaifenesin TABLET, EXTENDED RELEASE;ORAL 091009-002 Sep 3, 2015 OTC No No ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076267-002 Feb 11, 2004 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 076172-001 Jun 16, 2004 AB1 RX No No ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 075604-001 Apr 10, 2002 AB1 RX No No ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 205811-001 Aug 19, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Actavis Labs

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-001 Approved Prior to Jan 1, 1982 3,546,226 ➤ Sign Up
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-004 Approved Prior to Jan 1, 1982 3,546,226 ➤ Sign Up
Actavis Labs Ut Inc LOXITANE IM loxapine hydrochloride INJECTABLE;INJECTION 018039-001 Approved Prior to Jan 1, 1982 3,546,226 ➤ Sign Up
Actavis Labs Ut Inc LOXITANE C loxapine hydrochloride CONCENTRATE;ORAL 017658-001 Approved Prior to Jan 1, 1982 3,546,226 ➤ Sign Up
Actavis Labs Ut Inc EMLA lidocaine; prilocaine CREAM;TOPICAL 019941-001 Dec 30, 1992 4,529,601 ➤ Sign Up
Actavis Labs Ut Inc EMLA lidocaine; prilocaine CREAM;TOPICAL 019941-001 Dec 30, 1992 4,562,060 ➤ Sign Up
Actavis Labs Ut Inc LOXITANE C loxapine hydrochloride CONCENTRATE;ORAL 017658-001 Approved Prior to Jan 1, 1982 4,049,809 ➤ Sign Up
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-002 Approved Prior to Jan 1, 1982 3,546,226 ➤ Sign Up
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-003 Approved Prior to Jan 1, 1982 3,546,226 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ACTAVIS LABS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 6/3/2015
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Deloitte
Cipla
McKesson
UBS
US Army
Julphar
QuintilesIMS
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot